Clinical Trial

Robotic-assisted Bronchoscopy Under Moderate Sedation With Propofol

Study acronym: Robofol
Terminated
View on ClinicalTrials.gov →
Why the trial stopped
After enrolment of 10 patients, key study personnel left the institution, making continuation of the study at the current site no longer feasible.
Summary
In this study, the investigators want to find out whether robot-assisted bronchoscopy also works with moderate sedation (Propofol), as is already used in standard bronchoscopies. The study is being conducted as a pilot study. This means that it is an initial test run for a scientific investigation. The investigators are testing on a small scale whether the intervention works as predicted before a larger study is conducted.
Protocol Amendment History 2 changes
critical Trial terminated 2026-07-25
notable Enrollment reduced: 30 -> 10 participants 2026-07-25
Trial Details
NCT Number NCT07006311
Lead Sponsor University of Zurich
Conditions Lung Lesions, Robotic Assisted Bronchoscopy, Propofol, Bronchoscopy, Bronchoscopy Biopsy
Enrollment 10 participants
Start Date 2025-08-14
Primary Completion 2026-06-20 (estimated)
Study Completion 2026-06-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-24